Skip to main content

Table 3 The names and median cycles of regimens used as adjuvant chemotherapy

From: The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer

Regimens

Number

Percent

Cycles

Doxifluridine (D1–28) q 4w

205

47.7

19.9

UFT (D1–28) q 4w

57

13.3

11.9

S-1 (D1–28) q 6w

51

11.9

5.0

Capecitabine (D1–14) + cisplatin (D1) q 3w

48

11.2

6.8

5-FU (D1–5) + cisplatin (D1) q 3w

44

10.2

5.7

S-1 (D1–14) + cisplatin (D1)

18

4.2

5.7

Oxaliplatin (D1) + leucovorin (D1–2) + 5-FU (D1–2) q 2w

7

1.6

12.6

  1. n number of patients, q every, w weeks, D day